Natrecor (nesiritide), a new IV drug for treating patients who are hospitalized with acute CHF.
September 2001
You'll soon see patients on Natrecor (nesiritide), a new IV drug for treating patients who are hospitalized with acute CHF.
It's in a new drug class...human B-type natriuretic peptide (hBNP).
Natrecor is a recombinant version of this peptide...and has vasodilatory and diuretic effects.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote